By inhibiting FGFR1 phosphorylation and its downstream signaling pathway in gastric cancer cells, it inhibited the growth, migration, and survival of cancer cells, as well as enhancing the chemosensitivity of cancer cells to 5-FU. This evidence concerns the gene FGFR1 and cancer.